Overview

Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis

Status:
Terminated

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

The study will evaluate how effective and how safe the drug micafungin is when compared to the drug amphotericin B deoxycholate in treating neonates and young infants with certain fungal infections.

Phase:

Phase 3

Details

Lead Sponsor:

Astellas Pharma Global Development, Inc.

Treatments:

Amphotericin B
Amphotericin B, deoxycholate drug combination
Deoxycholic Acid
Echinocandins
Liposomal amphotericin B
Micafungin